Lifetime Prevalence of Acne is Over 90% in People of All Ages, Says Black Swan Analysis in Its Report Published at MarketPublishers.com

05 Jan 2017 • by Natalie Aster

LONDON – Acne, or acne vulgaris (AV), is a chronic inflammatory skin condition that affects practically all adolescents and adults at a certain point in their lives. The clinical presentation of acne varies from a mild form of acne to severe inflammatory cystic acne of the chest, face, and back.

Worldwide, the lifetime prevalence of the disease is more than 90% in people of all ages, and acne’s point prevalence stands at close to 85% in the population aged between 15 and 24 years.

The coming years are expected to see a hike in the total prevalent cases of acne in people aged 10 to 44 across the leading markets. The upsurge in prevalent cases in each country market is due to the demographics changes with respect to people of 10-44 years old in the markets in question.

There is a need for preventive measures focused on high-risk groups as well as the need for early intervention with the current effective therapies to tackle the rising burden of acne.

New comprehensive research report “Epiomic Epidemiology Series: Acne Vulgaris Forecast in 15 Major Markets 2016-2026” developed by Black Swan Analysis examines the current prevalent population for AV in the top 15 markets such as the USA, France, Canada, Russia, Germany, the UK, Spain, Poland, Italy, Australia, China, Turkey, Japan, Brazil and India; the data is broken down on the basis of gender and 5-year age cohort.

Reasons to Buy:

• Get information on patient populations in the global AV market to target the product developments, pricing strategies and launch plans.
• Gain deep insights into the prevalence of the subdivided AV types and pinpoint high-potential patient segments.
• Get access to detailed information for clinical trials.
• Gain a detailed understanding on the influence of certain co-morbid conditions on AV prevalent population.
• Discover sub-populations within AV which are in need of treatment.
• Find out about specific markets that have the biggest number of patients with AV.

More insightful reports by Black Swan Analysis are provided at its page. 

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com